{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T23:38:12Z","timestamp":1792971492766,"version":"4.5.0"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,5,1]]},"DOI":"10.2169\/internalmedicine.6020-25","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T22:08:27Z","timestamp":1759356507000},"page":"1210-1215","source":"Crossref","is-referenced-by-count":1,"title":["Mucosa-associated Lymphoid Tissue Lymphoma of the Stomach Associated with a &lt;i&gt;Helicobacter heilmannii&lt;\/i&gt; sensu stricto Infection One Year after the Successful Eradication of &lt;i&gt;Helicobacter pylori&lt;\/i&gt;"],"prefix":"10.2169","volume":"65","author":[{"given":"Daisuke","family":"Fujihara","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Kurimoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikue","family":"Sekai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Masuta","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Masaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Honjo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Chikugo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kindai University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Zucca E, Bertoni F. The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance. Blood 127: 2082-2092, 2016.","DOI":"10.1182\/blood-2015-12-624304"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Rodriguez-Sevilla JJ, Salar A. Recent advances in the genetic of MALT lymphomas. Cancers (Basel) 14: 2021.","DOI":"10.3390\/cancers14010176"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Asano N, Iijima K, Koike T, Imatani A, Shimosegawa T. <i>Helicobacter pylori<\/i>-negative gastric mucosa-associated lymphoid tissue lymphomas: a review. World J Gastroenterol 21: 8014-8020, 2015.","DOI":"10.3748\/wjg.v21.i26.8014"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Luminari S, Cesaretti M, Marcheselli L, et al. Decreasing incidence of gastric MALT lymphomas in the era of anti-<i>Helicobacter pylori<\/i> interventions: results from a population-based study on extranodal marginal zone lymphomas. Ann Oncol 21: 855-859, 2010.","DOI":"10.1093\/annonc\/mdp402"},{"key":"5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/gutjnl-2011-300495","volume":"61","author":"S Nakamura","year":"2012","unstructured":"5. Nakamura S, Sugiyama T, Matsumoto T, et al. Long-term clinical outcome of gastric MALT lymphoma after eradication of <i>Helicobacter pylori<\/i>: a multicentre cohort follow-up study of 420 patients in Japan. Gut 61: 507-513, 2012.","journal-title":"Gut","ISSN":"https:\/\/id.crossref.org\/issn\/0017-5749","issn-type":"print"},{"key":"6","unstructured":"6. Zullo A, Hassan C, Ridola L, Repici A, Manta R, Andriani A. Gastric MALT lymphoma: old and new insights. Ann Gastroenterol 27: 27-33, 2014."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Asano N, Iijima K, Terai S, et al. Eradication therapy is effective for <i>Helicobacter pylori<\/i>-negative gastric mucosa-associated lymphoid tissue lymphoma. Tohoku J Exp Med 228: 223-227, 2012.","DOI":"10.1620\/tjem.228.223"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Takigawa H, Yuge R, Masaki S, et al. Involvement of non-<i>Helicobacter pylori<\/i> helicobacter infections in <i>Helicobacter pylori<\/i>-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy. Gastric Cancer 24: 937-945, 2021.","DOI":"10.1007\/s10120-021-01172-x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Takigawa H, Masaki S, Naito T, et al. <i>Helicobacter suis<\/i> infection is associated with nodular gastritis-like appearance of gastric mucosa-associated lymphoid tissue lymphoma. Cancer Med 8: 4370-4379, 2019.","DOI":"10.1002\/cam4.2314"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. \u00d8verby A, Murayama SY, Michimae H, et al. Prevalence of gastric non-<i>Helicobacter pylori<\/i>-Helicobacters in Japanese patients with gastric disease. Digestion 95: 61-66, 2017.","DOI":"10.1159\/000452400"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Naito T, Yuge R, Tanaka S, et al. Gastric mucosa-associated lymphoid tissue lymphoma in conjunction with multiple lymphomatous polyposis in the context of <i>Helicobacter pylori<\/i> and <i>Helicobacter suis<\/i> superinfection. Clin J Gastroenterol 14: 478-483, 2021.","DOI":"10.1007\/s12328-020-01310-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Okamura T, Iwaya Y, Yokosawa S, et al. A case of <i>Helicobacter heilmannii<\/i>-associated primary gastric mucosa-associated lymphoid tissue lymphoma achieving complete remission after eradication. Clin J Gastroenterol 6: 38-45, 2013.","DOI":"10.1007\/s12328-012-0355-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yasuda T, Lee HS, Nam SY, et al. Non-<i>Helicobacter pylori Helicobacter<\/i> (NHPH) positive gastric cancer. Sci Rep 12: 4811, 2022.","DOI":"10.1038\/s41598-022-08962-y"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yoshikawa T, Minaga K, Hara A, et al. Disruption of the intestinal barrier exacerbates experimental autoimmune pancreatitis by promoting the translocation of <i>Staphylococcus sciuri<\/i> into the pancreas. Int Immunol 34: 621-634, 2022.","DOI":"10.1093\/intimm\/dxac039"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kurimoto M, Honjo H, Yoshida S, et al. Enlargement of gastric hyperplastic polyps arising from <i>Helicobacter heilmannii<\/i> sensu stricto-infected mucosa after the successful eradication of <i>Helicobacter pylori<\/i> and the long-term use of a proton pump inhibitor. Intern Med 64: 1677-1683, 2025.","DOI":"10.2169\/internalmedicine.4230-24"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Bento-Miranda M, Figueiredo C. <i>Helicobacter heilmannii sensu lato<\/i>: an overview of the infection in humans. World J Gastroenterol 20: 17779-17787, 2014.","DOI":"10.3748\/wjg.v20.i47.17779"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Taillieu E, Chiers K, Amorim I, et al. Gastric <i>Helicobacter<\/i> species associated with dogs, cats and pigs: significance for public and animal health. Vet Res 53: 42, 2022.","DOI":"10.1186\/s13567-022-01059-4"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Tsukadaira T, Hayashi S, Ota H, et al. Triple-drug combination therapy versus six-month proton pump inhibitor monotherapy in non-<i>Helicobacter pylori Helicobacter<\/i> eradication, and hyperacid environment preference of <i>Helicobacter suis<\/i>: a clinical study. BMC Gastroenterol 24: 157, 2024.","DOI":"10.1186\/s12876-024-03252-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Nakamura M, Matsui H, Takahashi T, et al. Suppression of lymphangiogenesis induced by Flt-4 antibody in gastric low-grade mucosa-associated lymphoid tissue lymphoma by <i>Helicobacter heilmannii<\/i> infection. J Gastroenterol Hepatol 25 (Suppl 1): S1-S6, 2010.","DOI":"10.1111\/j.1440-1746.2010.06230.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Nakamura M, Takahashi T, Matsui H, et al. Alteration of angiogenesis in <i>Helicobacter heilmannii<\/i>-induced mucosa-associated lymphoid tissue lymphoma: interaction with c-Met and hepatocyte growth factor. J Gastroenterol Hepatol 29 (Suppl 4): 70-76, 2014.","DOI":"10.1111\/jgh.12776"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Chen XY, Liu WZ, Shi Y, Zhang DZ, Xiao SD, Tytgat GN. <i>Helicobacter pylori<\/i> associated gastric diseases and lymphoid tissue hyperplasia in gastric antral mucosa. J Clin Pathol 55: 133-137, 2002.","DOI":"10.1136\/jcp.55.2.133"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Eidt S, Stolte M. Prevalence of lymphoid follicles and aggregates in <i>Helicobacter pylori<\/i> gastritis in antral and body mucosa. J Clin Pathol 46: 832-835, 1993.","DOI":"10.1136\/jcp.46.9.832"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/9\/65_6020-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:22:09Z","timestamp":1777692129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/9\/65_6020-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6020-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"article-number":"6020-25"}}